Insider trades › Eli Lilly › David Ricks
David Ricks: Eli Lilly stock transactions
David Ricks (President, Chair, and CEO, Director at Eli Lilly) reported 1 transaction in LLY stock on SEC Form 4 over the last 120 days. Name as filed with the SEC: Ricks David A.
$0open-market sales (0 shares)
$0open-market purchases (0 shares)
2026-11-03most recent transaction
Transactions
| Date | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Nov 3, 2026 | Gift | 23,538 | — | — | Form 4 ↗ |
Source: SEC EDGAR Form 4 filings; each row links to the filing. Sales marked "10b5-1 plan" were reported as made under a pre-arranged trading plan. Insider trades are reported facts, not recommendations. Not investment advice.